Fig. 8From: PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, relieves airway hyperresponsiveness, mucus hypersecretion and inflammation in a murine asthma modelPP121 inhibited VEGF and MAPK/Akt signaling pathways in lung tissues. A–C The western blot band (left panel) and bar graph (right panel) show the ratio of p-VEGR2 to VEGFR2, p-Akt to Akt and p-p38 MAPK to p38 MAPK in the control, asthma, Dex and PP121 groups, respectively. *p < 0.05; **p < 0.01Back to article page